Synergy Pharmaceuticals Inc (SGYP): Synergy Pharmaceuticals' Upcoming Trial

Synergy Pharmaceuticals Inc (SGYP): Synergy Pharmaceuticals' Upcoming Trial
An often troublesome side effect for constipation treatments, diarrhea incidence was observed to be 9.7% (vs. placebo incidence of 1.3%) at the 3 mg dosage. Synergy's likely nearest-term catalyst will likely come from it Phase II trial evaluating …
Read more on Seeking Alpha

Comments are closed.